Safety, Tolerability, and Pharmacokinetic Evaluations of CKR-051 After Transdermal Administration in Healthy Male Subjects
Clinical trial NCT05833906 · COMPLETED
Trial details
- NCT number
- NCT05833906
- Sponsor
- CK Regeon Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2024-01-08
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.